Christian Prehn
St. Josef Hospital
Bochum, NW, Germany
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period.
Journal: Journal of neurology
Published: July 17, 2025
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 11, 2024
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
Journal: Journal of neurology
Published: March 27, 2024
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy.
Journal: European journal of neurology
Published: June 16, 2020
Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla.
Journal: Frontiers in neurology
Published: September 01, 2019
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Journal: CNS neuroscience & therapeutics
Published: June 15, 2016
Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Journal: PloS one
Published: December 06, 2014
Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.
Journal: Journal of neurology
Published: July 30, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026